Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9

Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of c...

Full description

Saved in:
Bibliographic Details
Published inCancer letters Vol. 289; no. 1; pp. 53 - 61
Main Authors Kenig, Saša, Alonso, María Beatriz Durán, Mueller, Margareta M., Lah, Tamara T.
Format Journal Article
LanguageEnglish
Published Ireland Elsevier Ireland Ltd 01.03.2010
Elsevier Limited
Subjects
HIF
NGF
GBM
GF
Online AccessGet full text

Cover

Loading…
Abstract Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of cells. Using the in vitro model, we demonstrate that co-culturing of U87 (human glioblastoma) cells with HMEC-1 (human microvascular endothelial) cells increases the invasiveness of the U87 cells. The enhanced invasiveness correlates with increased expression of MMP-9 in both U87 and HMEC-1 cells, increased expression of cysteine cathepsins B and S and down-regulation of endogenous cell adhesion molecule NCAM in U87 cells. On the other hand, U87 tumour cells significantly enhance the proliferation of co-cultured endothelial cells by a mechanism involving cathepsin B, but not cathepsin S. Furthermore, we demonstrated that increased cell expression and activity of MMP-9 in cell microenvironment is mediated via secretion of SDF-1 by HMEC-1 cells. Selective SDF-1 inhibition impaired the enhanced U87 cell invasion, mostly via down-regulation of MMP-9, but did not alter cathepsin B, although the latter is more relevant for the invasion of U87 cells in mono-culture. Taken together, our study suggests that glioblastoma cells may be attracted by endothelial cells, enhancing their proliferation and underlines the importance of SDF-1, cathepsin B and MMP-9 in the cross-talk between these cells in normoxic conditions. This notion contributes to better understanding and suggests further investigations of the paracrine mechanisms, regulating glioma angiogenesis.
AbstractList Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of cells. Using thein vitromodel, we demonstrate that co-culturing of U87 (human glioblastoma) cells with HMEC-1 (human microvascular endothelial) cells increases the invasiveness of the U87 cells. The enhanced invasiveness correlates with increased expression of MMP-9 in both U87 and HMEC-1 cells, increased expression of cysteine cathepsins B and S and down-regulation of endogenous cell adhesion molecule NCAM in U87 cells. On the other hand, U87 tumour cells significantly enhance the proliferation of co-cultured endothelial cells by a mechanism involving cathepsin B, but not cathepsin S. Furthermore, we demonstrated that increased cell expression and activity of MMP-9 in cell microenvironment is mediated via secretion of SDF-1 by HMEC-1 cells. Selective SDF-1 inhibition impaired the enhanced U87 cell invasion, mostly via down-regulation of MMP-9, but did not alter cathepsin B, although the latter is more relevant for the invasion of U87 cells in mono-culture. Taken together, our study suggests that glioblastoma cells may be attracted by endothelial cells, enhancing their proliferation and underlines the importance of SDF-1, cathepsin B and MMP-9 in the cross-talk between these cells in normoxic conditions. This notion contributes to better understanding and suggests further investigations of the paracrine mechanisms, regulating glioma angiogenesis.
Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of cells. Using the in vitro model, we demonstrate that co-culturing of U87 (human glioblastoma) cells with HMEC-1 (human microvascular endothelial) cells increases the invasiveness of the U87 cells. The enhanced invasiveness correlates with increased expression of MMP-9 in both U87 and HMEC-1 cells, increased expression of cysteine cathepsins B and S and down-regulation of endogenous cell adhesion molecule NCAM in U87 cells. On the other hand, U87 tumour cells significantly enhance the proliferation of co-cultured endothelial cells by a mechanism involving cathepsin B, but not cathepsin S. Furthermore, we demonstrated that increased cell expression and activity of MMP-9 in cell microenvironment is mediated via secretion of SDF-1 by HMEC-1 cells. Selective SDF-1 inhibition impaired the enhanced U87 cell invasion, mostly via down-regulation of MMP-9, but did not alter cathepsin B, although the latter is more relevant for the invasion of U87 cells in mono-culture. Taken together, our study suggests that glioblastoma cells may be attracted by endothelial cells, enhancing their proliferation and underlines the importance of SDF-1, cathepsin B and MMP-9 in the cross-talk between these cells in normoxic conditions. This notion contributes to better understanding and suggests further investigations of the paracrine mechanisms, regulating glioma angiogenesis.
Abstract Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of cells. Using the in vitro model, we demonstrate that co-culturing of U87 (human glioblastoma) cells with HMEC-1 (human microvascular endothelial) cells increases the invasiveness of the U87 cells. The enhanced invasiveness correlates with increased expression of MMP-9 in both U87 and HMEC-1 cells, increased expression of cysteine cathepsins B and S and down-regulation of endogenous cell adhesion molecule NCAM in U87 cells. On the other hand, U87 tumour cells significantly enhance the proliferation of co-cultured endothelial cells by a mechanism involving cathepsin B, but not cathepsin S. Furthermore, we demonstrated that increased cell expression and activity of MMP-9 in cell microenvironment is mediated via secretion of SDF-1 by HMEC-1 cells. Selective SDF-1 inhibition impaired the enhanced U87 cell invasion, mostly via down-regulation of MMP-9, but did not alter cathepsin B, although the latter is more relevant for the invasion of U87 cells in mono-culture. Taken together, our study suggests that glioblastoma cells may be attracted by endothelial cells, enhancing their proliferation and underlines the importance of SDF-1, cathepsin B and MMP-9 in the cross-talk between these cells in normoxic conditions. This notion contributes to better understanding and suggests further investigations of the paracrine mechanisms, regulating glioma angiogenesis.
Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of cells. Using the in vitro model, we demonstrate that co-culturing of U87 (human glioblastoma) cells with HMEC-1 (human microvascular endothelial) cells increases the invasiveness of the U87 cells. The enhanced invasiveness correlates with increased expression of MMP-9 in both U87 and HMEC-1 cells, increased expression of cysteine cathepsins B and S and down-regulation of endogenous cell adhesion molecule NCAM in U87 cells. On the other hand, U87 tumour cells significantly enhance the proliferation of co-cultured endothelial cells by a mechanism involving cathepsin B, but not cathepsin S. Furthermore, we demonstrated that increased cell expression and activity of MMP-9 in cell microenvironment is mediated via secretion of SDF-1 by HMEC-1 cells. Selective SDF-1 inhibition impaired the enhanced U87 cell invasion, mostly via down-regulation of MMP-9, but did not alter cathepsin B, although the latter is more relevant for the invasion of U87 cells in mono-culture. Taken together, our study suggests that glioblastoma cells may be attracted by endothelial cells, enhancing their proliferation and underlines the importance of SDF-1, cathepsin B and MMP-9 in the cross-talk between these cells in normoxic conditions. This notion contributes to better understanding and suggests further investigations of the paracrine mechanisms, regulating glioma angiogenesis.
Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of cells. Using the in vitro model, we demonstrate that co-culturing of U87 (human glioblastoma) cells with HMEC-1 (human microvascular endothelial) cells increases the invasiveness of the U87 cells. The enhanced invasiveness correlates with increased expression of MMP-9 in both U87 and HMEC-1 cells, increased expression of cysteine cathepsins B and S and down-regulation of endogenous cell adhesion molecule NCAM in U87 cells. On the other hand, U87 tumour cells significantly enhance the proliferation of co-cultured endothelial cells by a mechanism involving cathepsin B, but not cathepsin S. Furthermore, we demonstrated that increased cell expression and activity of MMP-9 in cell microenvironment is mediated via secretion of SDF-1 by HMEC-1 cells. Selective SDF-1 inhibition impaired the enhanced U87 cell invasion, mostly via down-regulation of MMP-9, but did not alter cathepsin B, although the latter is more relevant for the invasion of U87 cells in mono-culture. Taken together, our study suggests that glioblastoma cells may be attracted by endothelial cells, enhancing their proliferation and underlines the importance of SDF-1, cathepsin B and MMP-9 in the cross-talk between these cells in normoxic conditions. This notion contributes to better understanding and suggests further investigations of the paracrine mechanisms, regulating glioma angiogenesis.Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of cells. Using the in vitro model, we demonstrate that co-culturing of U87 (human glioblastoma) cells with HMEC-1 (human microvascular endothelial) cells increases the invasiveness of the U87 cells. The enhanced invasiveness correlates with increased expression of MMP-9 in both U87 and HMEC-1 cells, increased expression of cysteine cathepsins B and S and down-regulation of endogenous cell adhesion molecule NCAM in U87 cells. On the other hand, U87 tumour cells significantly enhance the proliferation of co-cultured endothelial cells by a mechanism involving cathepsin B, but not cathepsin S. Furthermore, we demonstrated that increased cell expression and activity of MMP-9 in cell microenvironment is mediated via secretion of SDF-1 by HMEC-1 cells. Selective SDF-1 inhibition impaired the enhanced U87 cell invasion, mostly via down-regulation of MMP-9, but did not alter cathepsin B, although the latter is more relevant for the invasion of U87 cells in mono-culture. Taken together, our study suggests that glioblastoma cells may be attracted by endothelial cells, enhancing their proliferation and underlines the importance of SDF-1, cathepsin B and MMP-9 in the cross-talk between these cells in normoxic conditions. This notion contributes to better understanding and suggests further investigations of the paracrine mechanisms, regulating glioma angiogenesis.
Author Kenig, Saša
Mueller, Margareta M.
Alonso, María Beatriz Durán
Lah, Tamara T.
Author_xml – sequence: 1
  givenname: Saša
  surname: Kenig
  fullname: Kenig, Saša
  email: sasa.kenig@nib.si
  organization: Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna Pot 111, Ljubljana, Slovenia
– sequence: 2
  givenname: María Beatriz Durán
  surname: Alonso
  fullname: Alonso, María Beatriz Durán
  organization: Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna Pot 111, Ljubljana, Slovenia
– sequence: 3
  givenname: Margareta M.
  surname: Mueller
  fullname: Mueller, Margareta M.
  organization: Research Group Tumour and Microenvironment, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg, Germany
– sequence: 4
  givenname: Tamara T.
  surname: Lah
  fullname: Lah, Tamara T.
  email: tamara.lah@nib.si
  organization: Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna Pot 111, Ljubljana, Slovenia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19700239$$D View this record in MEDLINE/PubMed
BookMark eNqVktFuFCEYhYmpsdvqGxhD4oU3OysMwzIYY6LVVpM2mqxeEwb-sawsswLbuE_lK8rsVk1qtPGCcME5H3D-c4QOwhAAoYeUzCih86fLmdHBQ57VhMgZETNCmztoQltRV0K25ABNCCNNxVrGD9FRSktCCG8Ev4cOqRSE1ExO0Pcz74bO65SHlcY6WAzBDvkSvNMeG_A-YROHlKqs_ZcpXoF1OoPF3RYvXp9WdFoMlzoYSDhvVsMmYheudHJD-IO2joN3PUSdx9MCcMFEKNrwGcO3dYS0sw09Nrp41uUg4VdTvJjuUBcXHyp5H93ttU_w4Ho_Rp9O33w8eVudvz97d_LyvDK8lrlqNOtkK5g0opmbuqM1WFGTntkemGGcm1o2PZdzKXhNat1RazvLLWO6GFrLjtGTPbc8-usGUlYrl8Y4dIBhk5RouGSk5fPblYy1lPKGF-XjG8plySuUbyjKyZyUJUbeo2vVpitpq3V0Kx236ufMiuDZXrCbS4ReGZd3meaonVeUqLEgaqn2BVFjQRQRqhSkmJsb5l_8f9te7G1QMr9yEFUyDsrUrYtgsrKD-1-A8S44U0oFW0i_g1CpVkQtxuqOzSWylLZ8uwCe_x1w-_0_APuVAF4
CitedBy_id crossref_primary_10_1007_s11060_010_0158_0
crossref_primary_10_1063_1_5089772
crossref_primary_10_1016_j_neo_2015_10_002
crossref_primary_10_1016_j_freeradbiomed_2013_07_020
crossref_primary_10_1186_s12935_016_0364_8
crossref_primary_10_1158_1541_7786_MCR_11_0411
crossref_primary_10_1016_j_bbcan_2011_12_001
crossref_primary_10_1371_journal_pone_0013973
crossref_primary_10_1002_glia_23309
crossref_primary_10_1007_s12672_024_01547_3
crossref_primary_10_1007_s10014_011_0077_6
crossref_primary_10_1186_s12883_021_02477_1
crossref_primary_10_1016_j_bbamcr_2016_12_021
crossref_primary_10_1016_j_mvr_2010_11_005
crossref_primary_10_18632_oncotarget_2408
crossref_primary_10_1016_j_bbcan_2012_05_004
crossref_primary_10_1016_j_bbalip_2018_07_009
crossref_primary_10_1369_0022155415581689
crossref_primary_10_3390_cancers14030600
crossref_primary_10_1016_j_bbamcr_2020_118781
crossref_primary_10_3109_09553002_2014_930539
crossref_primary_10_1371_journal_pone_0103938
crossref_primary_10_1159_000111048
crossref_primary_10_3892_mmr_2013_1703
crossref_primary_10_1007_s13277_015_4202_8
crossref_primary_10_1038_labinvest_2011_128
crossref_primary_10_1007_s00401_013_1079_8
crossref_primary_10_1016_j_biochi_2013_11_013
crossref_primary_10_1038_s41698_019_0092_3
crossref_primary_10_1088_1054_660X_24_11_115602
crossref_primary_10_4155_fsoa_2016_0094
crossref_primary_10_1002_adhm_201701257
crossref_primary_10_1007_s40139_013_0012_0
crossref_primary_10_12677_acm_2024_14102670
crossref_primary_10_18632_oncotarget_969
crossref_primary_10_1016_j_tips_2011_02_015
crossref_primary_10_1186_s13578_023_01040_4
crossref_primary_10_1093_jnen_nlw054
crossref_primary_10_3390_ijms24087047
crossref_primary_10_2478_raon_2018_0040
crossref_primary_10_1007_s10735_018_9787_y
crossref_primary_10_1158_1078_0432_CCR_18_1025
crossref_primary_10_1101_gad_250647_114
crossref_primary_10_1371_journal_pone_0033005
crossref_primary_10_1007_s11060_024_04870_5
crossref_primary_10_1039_D1BM00574J
crossref_primary_10_3389_fimmu_2023_1154146
crossref_primary_10_1002_path_4349
crossref_primary_10_3390_brainsci13040542
crossref_primary_10_1002_bit_24775
crossref_primary_10_1016_j_prp_2016_02_020
crossref_primary_10_1515_hsz_2016_0283
crossref_primary_10_1002_advs_202201888
crossref_primary_10_3390_ijms21093162
crossref_primary_10_1016_j_biomaterials_2019_02_024
crossref_primary_10_1016_j_semcancer_2015_08_010
crossref_primary_10_1126_sciadv_adn1607
crossref_primary_10_1038_s41590_022_01215_0
Cites_doi 10.1158/0008-5472.CAN-07-5127
10.1007/BF00144018
10.1016/j.cdp.2005.07.006
10.1242/jcs.00281
10.1016/j.canlet.2005.05.011
10.1016/j.bbrc.2005.07.113
10.1007/s00401-005-0991-y
10.1038/nrc1388
10.4049/jimmunol.154.4.1888
10.1158/0008-5472.CAN-05-4340
10.1182/blood-2005-08-3182
10.1016/S0002-9440(10)63641-3
10.1016/S0021-9258(19)49853-0
10.1016/S1535-6108(04)00111-4
10.2353/ajpath.2008.071197
10.1517/14712598.6.3.257
10.1002/jcb.20720
10.1093/carcin/bgm220
10.3171/jns.1995.83.2.0285
10.1038/nrc1187
10.1038/nrc1477
10.1038/nrc745
10.1515/BC.2001.094
10.1038/nrc1093
10.1093/carcin/bgi183
10.1038/nrc2067
10.1038/nrc1121
10.1096/fj.04-2140fje
10.1007/s007010050301
10.1074/jbc.M107736200
10.1097/01.cej.0000236259.88146.a4
10.1023/B:NEON.0000024241.05346.24
10.1159/000024520
10.1007/s004240000114
10.1016/j.yexcr.2006.12.027
10.1586/14737140.6.7.1087
10.1074/jbc.M509134200
10.1038/35036374
10.1038/sj.onc.1207338
10.1002/path.1876
10.1007/s00701-003-0097-z
10.1515/BC.2004.132
10.1158/1078-0432.CCR-04-1887
10.1038/nrc1075
10.1002/1096-9896(2000)9999:9999<::AID-PATH810>3.0.CO;2-1
10.1038/sj.onc.1207616
10.1007/s00701-003-0132-0
ContentType Journal Article
Copyright 2009 Elsevier Ireland Ltd
Elsevier Ireland Ltd
Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
Copyright Elsevier Limited Mar 1, 2010
Copyright_xml – notice: 2009 Elsevier Ireland Ltd
– notice: Elsevier Ireland Ltd
– notice: Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
– notice: Copyright Elsevier Limited Mar 1, 2010
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TO
7U9
H94
K9.
NAPCQ
7X8
7TK
DOI 10.1016/j.canlet.2009.07.014
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE


Neurosciences Abstracts

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1872-7980
EndPage 61
ExternalDocumentID 3242189421
19700239
10_1016_j_canlet_2009_07_014
S0304383509005023
1_s2_0_S0304383509005023
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29B
3O-
4.4
457
4CK
4G.
53G
5GY
5RE
5VS
6J9
6PF
7-5
71M
8FE
8FH
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABMZM
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
ADUVX
AEBSH
AEFWE
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AHHHB
AHMBA
AI.
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKEYQ
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HED
HMK
HMO
HVGLF
HZ~
IH2
IHE
J1W
K-O
KOM
LK8
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
UDS
VH1
WUQ
X7M
Z5R
ZGI
~G-
3V.
7RV
7X7
8C1
8FI
AACTN
AFCTW
AFKRA
AFKWA
AJOXV
AMFUW
AZQEC
BBNVY
BENPR
BHPHI
FYUFA
GUQSH
HCIFZ
M1P
M2M
M2O
M7P
RIG
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
DOVZS
EFLBG
F3I
LCYCR
XFK
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TO
7U9
H94
K9.
NAPCQ
7X8
7TK
ID FETCH-LOGICAL-c529t-4a3b98739c746c2b12ed720f3dfe3c355c294f596975202ab1ddbd5d33a7468d3
IEDL.DBID .~1
ISSN 0304-3835
1872-7980
IngestDate Fri Jul 11 02:13:15 EDT 2025
Fri Jul 11 07:14:16 EDT 2025
Sat Aug 23 13:22:02 EDT 2025
Thu Apr 03 07:04:55 EDT 2025
Tue Jul 01 01:29:42 EDT 2025
Thu Apr 24 23:04:04 EDT 2025
Fri Feb 23 02:29:35 EST 2024
Sun Feb 23 10:19:53 EST 2025
Tue Aug 26 17:54:52 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords HIF
VEGF
SDF-1
Glioblastoma invasion
MIP1α
NGF
G-CSF
bFGF
Adhesion molecules: NCAM
Angiogenesis
Chemokines (CXCL12/SDF-1)
GBM
Matrix metalloproteases
Cysteine cathepsins
GM-CSF
SF/HGF
TGFβ
Proteases and proteins: MMP
GAPDH
Cytokines: MCP-1
GF
TIMP
stromal-derived factor-1
transforming growth factor β
neural cell adhesion molecule
basic fibroblast growth factor
granulocyte-colony-stimulating factor
monocyte chemotactic protein-1
nerve growth factor
tissue inhibitor of metalloproteinases
growth factors
glyceraldehydes 3-phosphate dehydrogenise
scatter factor/hepatocyte growth factor
glioblastoma
vascular endothelial growth factor
hypoxia induced factor
granulocyte-macrophage colony-stimulating factor
matrix metalloproteinase
macrophage inflammatory protein 1alpha
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c529t-4a3b98739c746c2b12ed720f3dfe3c355c294f596975202ab1ddbd5d33a7468d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 19700239
PQID 1506050676
PQPubID 2031080
PageCount 9
ParticipantIDs proquest_miscellaneous_745930856
proquest_miscellaneous_733811545
proquest_journals_1506050676
pubmed_primary_19700239
crossref_citationtrail_10_1016_j_canlet_2009_07_014
crossref_primary_10_1016_j_canlet_2009_07_014
elsevier_sciencedirect_doi_10_1016_j_canlet_2009_07_014
elsevier_clinicalkeyesjournals_1_s2_0_S0304383509005023
elsevier_clinicalkey_doi_10_1016_j_canlet_2009_07_014
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-03-01
PublicationDateYYYYMMDD 2010-03-01
PublicationDate_xml – month: 03
  year: 2010
  text: 2010-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
– name: Clare
PublicationTitle Cancer letters
PublicationTitleAlternate Cancer Lett
PublicationYear 2010
Publisher Elsevier Ireland Ltd
Elsevier Limited
Publisher_xml – name: Elsevier Ireland Ltd
– name: Elsevier Limited
References Bergers, Benjamin (bib5) 2003; 3
Scala, Ottaiano, Ascierto, Cavalli, Simeone, Giuliano, Napolitano, Franco, Botti, Castello (bib40) 2005; 11
Lah, Duran Alonso, Van Noorden (bib7) 2006; 6
Rosenman, Shrikant, Dubb, Benveniste, Ransohoff (bib22) 1995; 154
Egeblad, Werb (bib30) 2002; 2
Bergers, Brekken, McMahon, Vu, Itoh, Tamaki, Tanzawa, Thorpe, Itohara, Werb, Hanahan (bib52) 2000; 2
Kos, Lah (bib28) 1998; 5
Wang, Sun, Kitamoto, Yang, Grubb, Chapman, Kalluri, Shi (bib41) 2006; 281
Semenza (bib4) 2003; 3
Salmaggi, Gelati, Pollo, Frigerio, Eoli, Silvani, Broggi, Ciusani, Croci, Boiardi, De Rossi (bib50) 2004; 67
Joyce, Baruch, Chehade, Meyer-Morse, Giraudo, Tsai, Greenbaum, Hager, Bogyo, Hanahan (bib36) 2004; 5
Tews, Nissen (bib21) 1998; 18
Yang, Chen, Jiang, Wang, Chen, Zhao, Feng, Xin, Shi, Bian (bib46) 2005; 335
Hong, Jiang, Kalkanis, Zhang, Zhang, DeCarvalho, Katakowski, Bobbitt, Mikkelsen, Chopp (bib44) 2006; 236
Jedeszko, Sloane (bib29) 2004; 385
Friedl, Wolf (bib8) 2003; 3/5
Tu, Ortega-Cava, Chen, Fernandes, Cavallo-Medved, Sloane, Band, Band (bib9) 2008; 86/22
Sathornsumetee, Rich (bib2) 2006; 6
Flannery, Gibson, Mirakhur, McQuaid, Greenan, Trimble, Walker, McCormick, Johnston (bib35) 2003; 163
Mikkelsen, Yan, Ho, Sameni, Sloane, Rosenblum (bib15) 1995; 83
Parmo-Cabanas, Molina-Ortiz, Matias-Roman, Garcia-Bernal, Carvajal-Vergara, Valle, Pandiella, Arroyo, Teixido (bib53) 2006; 208
Zeelenberg, Ruuls-Van Stalle, Roos (bib42) 2003; 63
Albini, Sporn (bib27) 2007; 7
Strojnik, Kavalar, Trinkaus, Lah (bib33) 2005; 29
Levičar, Nuttall, Lah (bib11) 2003; 145
Charalambous, Virrey, Kardosh, Jabbour, Qazi-Abdullah, Pen, Zidovetzki, Schonthal, Chen, Hofman (bib38) 2007; 313
Kondraganti, Mohanam, Chintala, Kin, Jasti, Nirmala, Lakka, Adachi, Kyritsis, Ali-Osman, Sawaya, Fuller, Rao (bib19) 2000; 60
Zagzag, Esancay, Mendez, Yee, Smirnova, Huang, Chiribon, Lukyanov, Liu, Newcomb (bib51) 2008; 173
Scotton, Wilson, Scott, Stamp, Wilbanks, Fricker, Bridger, Balkwill (bib43) 2002; 62
Rao (bib10) 2003; 3
von Bulow, Hayen, Hartmann, Mueller-Klieser, Allolio, Nehls (bib6) 2001; 193
Sameni, Dosescu, Sloane (bib16) 2001; 382
Lakka, Gondi, Yanamandra, Olivero, Dinh, Gujrati, Rao (bib17) 2004; 23
Balkwill (bib25) 2004; 4
Khodarev, Yu, Labay, Darga, Brown, Mauceri, Yassari, Gupta, Weichselbaum (bib37) 2003; 116
Goldbrunner, Bernstein, Tonn (bib20) 1999; 141
Masson, de la Ballina, Munaut, Wielockx, Jost, Maillard, Blacher, Bajou, Itoh, Itohara, Werb, Libert, Foidart, Noel (bib31) 2005; 19
Park, Park, Kwak, Lee, Kim, Lee, Park, Rhee, Hong (bib32) 2006; 66
Premzl, Turk, Kos (bib18) 2006; 97
Burger, Kipps (bib26) 2006; 107
Folkman, Shing (bib3) 1992; 267
Sivaparvathi, Sawaya, Wang, Rayford, Yamamoto, Liotta, Nicolson, Rao (bib14) 1995; 13
Mueller, Fusenig (bib24) 2004; 4
Tang, Tan, Fu, Yang (bib48) 2008; 29
Yuecheng, Xiaoyan (bib47) 2007; 16
Strojnik, Zajc, Bervar, Zidanik, Golouh, Kos, Dolenc, Lah (bib12) 2000; 439
Mueller, Werbowetski, Del Maestro (bib23) 2003; 145
Zajc, Hreljac, Lah (bib34) 2006; 26
Zhang, Sarkar, Yong (bib45) 2005; 26
Strojnik, Kos, Zidanik, Lah (bib13) 1999; 5
McQuibban, Butler, Gong, Bendall, Power, Clark-Lewis, Overall (bib49) 2001; 276
Yanamandra, Gumidyala, Waldron, Gujrati, Olivero, Dinh, Rao, Mohanam (bib39) 2004; 23
Ohgaki, Kleihues (bib1) 2005; 109
Joyce (10.1016/j.canlet.2009.07.014_bib36) 2004; 5
Mueller (10.1016/j.canlet.2009.07.014_bib24) 2004; 4
Masson (10.1016/j.canlet.2009.07.014_bib31) 2005; 19
Tu (10.1016/j.canlet.2009.07.014_bib9) 2008; 86/22
Zajc (10.1016/j.canlet.2009.07.014_bib34) 2006; 26
Yuecheng (10.1016/j.canlet.2009.07.014_bib47) 2007; 16
Park (10.1016/j.canlet.2009.07.014_bib32) 2006; 66
Strojnik (10.1016/j.canlet.2009.07.014_bib13) 1999; 5
Sathornsumetee (10.1016/j.canlet.2009.07.014_bib2) 2006; 6
Flannery (10.1016/j.canlet.2009.07.014_bib35) 2003; 163
Ohgaki (10.1016/j.canlet.2009.07.014_bib1) 2005; 109
Strojnik (10.1016/j.canlet.2009.07.014_bib12) 2000; 439
Kondraganti (10.1016/j.canlet.2009.07.014_bib19) 2000; 60
Mikkelsen (10.1016/j.canlet.2009.07.014_bib15) 1995; 83
Zhang (10.1016/j.canlet.2009.07.014_bib45) 2005; 26
Scala (10.1016/j.canlet.2009.07.014_bib40) 2005; 11
Sameni (10.1016/j.canlet.2009.07.014_bib16) 2001; 382
Premzl (10.1016/j.canlet.2009.07.014_bib18) 2006; 97
Semenza (10.1016/j.canlet.2009.07.014_bib4) 2003; 3
Goldbrunner (10.1016/j.canlet.2009.07.014_bib20) 1999; 141
Parmo-Cabanas (10.1016/j.canlet.2009.07.014_bib53) 2006; 208
Levičar (10.1016/j.canlet.2009.07.014_bib11) 2003; 145
Charalambous (10.1016/j.canlet.2009.07.014_bib38) 2007; 313
Albini (10.1016/j.canlet.2009.07.014_bib27) 2007; 7
Tews (10.1016/j.canlet.2009.07.014_bib21) 1998; 18
Khodarev (10.1016/j.canlet.2009.07.014_bib37) 2003; 116
McQuibban (10.1016/j.canlet.2009.07.014_bib49) 2001; 276
Jedeszko (10.1016/j.canlet.2009.07.014_bib29) 2004; 385
Strojnik (10.1016/j.canlet.2009.07.014_bib33) 2005; 29
Yang (10.1016/j.canlet.2009.07.014_bib46) 2005; 335
Folkman (10.1016/j.canlet.2009.07.014_bib3) 1992; 267
Sivaparvathi (10.1016/j.canlet.2009.07.014_bib14) 1995; 13
Lakka (10.1016/j.canlet.2009.07.014_bib17) 2004; 23
Rosenman (10.1016/j.canlet.2009.07.014_bib22) 1995; 154
Egeblad (10.1016/j.canlet.2009.07.014_bib30) 2002; 2
Zeelenberg (10.1016/j.canlet.2009.07.014_bib42) 2003; 63
Zagzag (10.1016/j.canlet.2009.07.014_bib51) 2008; 173
Burger (10.1016/j.canlet.2009.07.014_bib26) 2006; 107
Tang (10.1016/j.canlet.2009.07.014_bib48) 2008; 29
Yanamandra (10.1016/j.canlet.2009.07.014_bib39) 2004; 23
Lah (10.1016/j.canlet.2009.07.014_bib7) 2006; 6
von Bulow (10.1016/j.canlet.2009.07.014_bib6) 2001; 193
Bergers (10.1016/j.canlet.2009.07.014_bib5) 2003; 3
Balkwill (10.1016/j.canlet.2009.07.014_bib25) 2004; 4
Hong (10.1016/j.canlet.2009.07.014_bib44) 2006; 236
Friedl (10.1016/j.canlet.2009.07.014_bib8) 2003; 3/5
Bergers (10.1016/j.canlet.2009.07.014_bib52) 2000; 2
Scotton (10.1016/j.canlet.2009.07.014_bib43) 2002; 62
Salmaggi (10.1016/j.canlet.2009.07.014_bib50) 2004; 67
Rao (10.1016/j.canlet.2009.07.014_bib10) 2003; 3
Kos (10.1016/j.canlet.2009.07.014_bib28) 1998; 5
Wang (10.1016/j.canlet.2009.07.014_bib41) 2006; 281
Mueller (10.1016/j.canlet.2009.07.014_bib23) 2003; 145
References_xml – volume: 86/22
  start-page: 9147
  year: 2008
  end-page: 9156
  ident: bib9
  article-title: Lysosomal cathepsins B participates in the podosome-mediated extracellular matrix degradation and invasion vi secreted lysosomes in the v-Src fibroblasts
  publication-title: Cancer Res.
– volume: 335
  start-page: 523
  year: 2005
  end-page: 528
  ident: bib46
  article-title: Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor
  publication-title: Biochem. Biophys. Rest. Commun.
– volume: 5
  start-page: 1349
  year: 1998
  end-page: 1361
  ident: bib28
  article-title: Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review)
  publication-title: Oncol. Rep.
– volume: 62
  start-page: 5930
  year: 2002
  end-page: 5938
  ident: bib43
  article-title: Multiple actions of the chemokine CXCL12 on epithelial tumour cells in human ovarian cancer
  publication-title: Cancer Rest.
– volume: 173
  start-page: 545
  year: 2008
  end-page: 560
  ident: bib51
  article-title: Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer’s structures
  publication-title: Am. J. Pathol.
– volume: 267
  start-page: 10931
  year: 1992
  end-page: 10934
  ident: bib3
  article-title: Angiogenesis
  publication-title: J. Biol. Chem.
– volume: 208
  start-page: 108
  year: 2006
  end-page: 118
  ident: bib53
  article-title: Role of metaloproteinases MMP9 and MT1-MMP in CXCL2-promoted myleoma cell invasion across basement membranes
  publication-title: J. Pathol.
– volume: 3
  start-page: 401
  year: 2003
  end-page: 410
  ident: bib5
  article-title: Tumourigenesis and the angiogenic switch
  publication-title: Nat. Rev. Cancer
– volume: 19
  start-page: 234
  year: 2005
  end-page: 236
  ident: bib31
  article-title: Contribution of host MMP-2 and MMP-9 to promote tumour vascularization and invasion of malignant keratinocytes
  publication-title: FASEB J.
– volume: 5
  start-page: 443
  year: 2004
  end-page: 453
  ident: bib36
  article-title: Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumourigenesis
  publication-title: Cancer Cell
– volume: 7
  start-page: 139
  year: 2007
  end-page: 147
  ident: bib27
  article-title: The tumour microenvirnment as a target for chemoprevetion
  publication-title: Nat. Rev. Cancer
– volume: 66
  start-page: 8511
  year: 2006
  end-page: 8519
  ident: bib32
  article-title: Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways
  publication-title: Cancer Rest.
– volume: 193
  start-page: 367
  year: 2001
  end-page: 376
  ident: bib6
  article-title: Endothelial capillaries chemotactically attract tumour cells
  publication-title: J. Pathol.
– volume: 3
  start-page: 489
  year: 2003
  end-page: 501
  ident: bib10
  article-title: Molecular mechanisms of glioma invasiveness: the role of proteases
  publication-title: Nat. Rev. Cancer
– volume: 18
  start-page: 271
  year: 1998
  end-page: 284
  ident: bib21
  article-title: Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumours
  publication-title: Invas. Metast.
– volume: 3
  start-page: 721
  year: 2003
  end-page: 732
  ident: bib4
  article-title: Targeting HIF-1 for cancer therapy
  publication-title: Nat. Rev. Cancer
– volume: 145
  start-page: 825
  year: 2003
  end-page: 838
  ident: bib11
  article-title: Proteases in brain tumour progression
  publication-title: Acta Neurochir. (Wien.)
– volume: 116
  start-page: 1013
  year: 2003
  end-page: 1022
  ident: bib37
  article-title: Tumour–endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells
  publication-title: J. Cell Sci.
– volume: 276
  start-page: 43503
  year: 2001
  end-page: 43508
  ident: bib49
  article-title: Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1
  publication-title: J. Biol. Chem.
– volume: 29
  start-page: 448
  year: 2005
  end-page: 455
  ident: bib33
  article-title: Cathepsin L in glioma progression: comparison with cathepsin B
  publication-title: Cancer Detect. Prev.
– volume: 4
  start-page: 839
  year: 2004
  end-page: 849
  ident: bib24
  article-title: Friends or foes – bipolar effects of the tumour stroma in cancer
  publication-title: Nat. Rev. Cancer
– volume: 163
  start-page: 175
  year: 2003
  end-page: 182
  ident: bib35
  article-title: The clinical significance of cathepsin S expression in human astrocytomas
  publication-title: Am. J. Pathol.
– volume: 63
  start-page: 3833
  year: 2003
  end-page: 3839
  ident: bib42
  article-title: The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases
  publication-title: Cancer Rest.
– volume: 281
  start-page: 6020
  year: 2006
  end-page: 6029
  ident: bib41
  article-title: Cathepsin S controls angiogenesis and tumour growth via matrix-derived angiogenic factors
  publication-title: J. Biol. Chem.
– volume: 107
  start-page: 1761
  year: 2006
  end-page: 1767
  ident: bib26
  article-title: CXCR4: a key receptor in the crosstalk between tumour cells and their microenvironment
  publication-title: Blood
– volume: 2
  start-page: 737
  year: 2000
  end-page: 744
  ident: bib52
  article-title: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogensis
  publication-title: Nat. Cell Biol.
– volume: 16
  start-page: 430
  year: 2007
  end-page: 435
  ident: bib47
  article-title: Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2
  publication-title: Eur. J. Cancer Prev.
– volume: 145
  start-page: 999
  year: 2003
  end-page: 1008
  ident: bib23
  article-title: Soluble factors involved in glioma invasion
  publication-title: Acta Neurochir. (Wien.)
– volume: 23
  start-page: 2224
  year: 2004
  end-page: 2230
  ident: bib39
  article-title: Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis
  publication-title: Oncogene
– volume: 26
  start-page: 2069
  year: 2005
  end-page: 2077
  ident: bib45
  article-title: The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase
  publication-title: Carcinogenesis
– volume: 11
  start-page: 1835
  year: 2005
  end-page: 1841
  ident: bib40
  article-title: Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma
  publication-title: Clin. Cancer Rest.
– volume: 2
  start-page: 161
  year: 2002
  end-page: 174
  ident: bib30
  article-title: New functions for the matrix metalloproteinases in cancer progression
  publication-title: Nat. Rev. Cancer
– volume: 313
  start-page: 1192
  year: 2007
  end-page: 1202
  ident: bib38
  article-title: Glioma-associated endothelial cells show evidence of replicative senescence
  publication-title: Exp. Cell Rest.
– volume: 29
  start-page: 35
  year: 2008
  end-page: 43
  ident: bib48
  article-title: Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis
  publication-title: Carcinogenesis
– volume: 3/5
  start-page: 362
  year: 2003
  end-page: 374
  ident: bib8
  article-title: Tumour-cell invasion and migration: diversity and escape mechanisms
  publication-title: Nat. Rev. Cancer
– volume: 4
  start-page: 540
  year: 2004
  end-page: 550
  ident: bib25
  article-title: Cancer and the chemokine network
  publication-title: Nat. Rev. Cancer
– volume: 382
  start-page: 785
  year: 2001
  end-page: 788
  ident: bib16
  article-title: Imaging proteolysis by living human glioma cells
  publication-title: Biol. Chem.
– volume: 385
  start-page: 1017
  year: 2004
  end-page: 1027
  ident: bib29
  article-title: Cysteine cathepsins in human cancer
  publication-title: Biol. Chem.
– volume: 60
  start-page: 6851
  year: 2000
  end-page: 6855
  ident: bib19
  article-title: Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion
  publication-title: Cancer Rest.
– volume: 109
  start-page: 93
  year: 2005
  end-page: 108
  ident: bib1
  article-title: Epidemiology and etiology of gliomas
  publication-title: Acta Neuropathpl.
– volume: 23
  start-page: 4681
  year: 2004
  end-page: 4689
  ident: bib17
  article-title: Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumour cell invasion, tumour growth and angiogenesis
  publication-title: Oncogene
– volume: 141
  start-page: 295
  year: 1999
  end-page: 305
  ident: bib20
  article-title: Cell–extracellular matrix interaction in glioma invasion
  publication-title: Acta Neurochir. (Wien.)
– volume: 439
  start-page: R122
  year: 2000
  end-page: R123
  ident: bib12
  article-title: Cathepsin B and its inhibitor stefin A in brain tumours
  publication-title: Pflugers Arch.
– volume: 67
  start-page: 305
  year: 2004
  end-page: 317
  ident: bib50
  article-title: CXCL12 in malignant glial tumours: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells
  publication-title: J. Neuro-Oncol.
– volume: 97
  start-page: 1230
  year: 2006
  end-page: 1240
  ident: bib18
  article-title: Intracellular proteolytic activity of cathepsin B is associated with capillary-like tube formation by endothelial cells in vitro
  publication-title: J. Cell Biochem.
– volume: 6
  start-page: 257
  year: 2006
  end-page: 279
  ident: bib7
  article-title: Antiprotease therapy in cancer: hot or not?
  publication-title: Expert Opin. Biol. Ther.
– volume: 6
  start-page: 1087
  year: 2006
  end-page: 1104
  ident: bib2
  article-title: New treatment strategies for malignant gliomas
  publication-title: Expert Rev. Anticancer Ther.
– volume: 83
  start-page: 285
  year: 1995
  end-page: 289
  ident: bib15
  article-title: Immunolocalization of cathepsin B in human glioma: implications for tumour invasion and angiogenesis
  publication-title: J. Neurosurg.
– volume: 236
  start-page: 39
  year: 2006
  end-page: 45
  ident: bib44
  article-title: SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion
  publication-title: Cancer Lett.
– volume: 13
  start-page: 49
  year: 1995
  end-page: 56
  ident: bib14
  article-title: Overexpression and localization of cathepsin B during the progression of human gliomas
  publication-title: Clin. Exp. Metast.
– volume: 154
  start-page: 1888
  year: 1995
  end-page: 1899
  ident: bib22
  article-title: Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines
  publication-title: J. Immunol.
– volume: 26
  start-page: 3357
  year: 2006
  end-page: 3364
  ident: bib34
  article-title: Cathepsin L affects apoptosis of glioblastoma cells: a potential implication in the design of cancer therapeutics
  publication-title: Anticancer Rest.
– volume: 5
  start-page: 559
  year: 1999
  end-page: 567
  ident: bib13
  article-title: Cathepsin B immunohistochemical staining in tumour, endothelial cells is a new prognostic factor for survival in patients with brain tumours
  publication-title: Clin. Cancer Rest.
– volume: 86/22
  start-page: 9147
  year: 2008
  ident: 10.1016/j.canlet.2009.07.014_bib9
  article-title: Lysosomal cathepsins B participates in the podosome-mediated extracellular matrix degradation and invasion vi secreted lysosomes in the v-Src fibroblasts
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-5127
– volume: 63
  start-page: 3833
  year: 2003
  ident: 10.1016/j.canlet.2009.07.014_bib42
  article-title: The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases
  publication-title: Cancer Rest.
– volume: 62
  start-page: 5930
  year: 2002
  ident: 10.1016/j.canlet.2009.07.014_bib43
  article-title: Multiple actions of the chemokine CXCL12 on epithelial tumour cells in human ovarian cancer
  publication-title: Cancer Rest.
– volume: 13
  start-page: 49
  year: 1995
  ident: 10.1016/j.canlet.2009.07.014_bib14
  article-title: Overexpression and localization of cathepsin B during the progression of human gliomas
  publication-title: Clin. Exp. Metast.
  doi: 10.1007/BF00144018
– volume: 29
  start-page: 448
  year: 2005
  ident: 10.1016/j.canlet.2009.07.014_bib33
  article-title: Cathepsin L in glioma progression: comparison with cathepsin B
  publication-title: Cancer Detect. Prev.
  doi: 10.1016/j.cdp.2005.07.006
– volume: 116
  start-page: 1013
  year: 2003
  ident: 10.1016/j.canlet.2009.07.014_bib37
  article-title: Tumour–endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells
  publication-title: J. Cell Sci.
  doi: 10.1242/jcs.00281
– volume: 236
  start-page: 39
  year: 2006
  ident: 10.1016/j.canlet.2009.07.014_bib44
  article-title: SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2005.05.011
– volume: 335
  start-page: 523
  year: 2005
  ident: 10.1016/j.canlet.2009.07.014_bib46
  article-title: Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor
  publication-title: Biochem. Biophys. Rest. Commun.
  doi: 10.1016/j.bbrc.2005.07.113
– volume: 109
  start-page: 93
  year: 2005
  ident: 10.1016/j.canlet.2009.07.014_bib1
  article-title: Epidemiology and etiology of gliomas
  publication-title: Acta Neuropathpl.
  doi: 10.1007/s00401-005-0991-y
– volume: 4
  start-page: 540
  year: 2004
  ident: 10.1016/j.canlet.2009.07.014_bib25
  article-title: Cancer and the chemokine network
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1388
– volume: 154
  start-page: 1888
  year: 1995
  ident: 10.1016/j.canlet.2009.07.014_bib22
  article-title: Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.154.4.1888
– volume: 66
  start-page: 8511
  year: 2006
  ident: 10.1016/j.canlet.2009.07.014_bib32
  article-title: Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways
  publication-title: Cancer Rest.
  doi: 10.1158/0008-5472.CAN-05-4340
– volume: 107
  start-page: 1761
  year: 2006
  ident: 10.1016/j.canlet.2009.07.014_bib26
  article-title: CXCR4: a key receptor in the crosstalk between tumour cells and their microenvironment
  publication-title: Blood
  doi: 10.1182/blood-2005-08-3182
– volume: 163
  start-page: 175
  year: 2003
  ident: 10.1016/j.canlet.2009.07.014_bib35
  article-title: The clinical significance of cathepsin S expression in human astrocytomas
  publication-title: Am. J. Pathol.
  doi: 10.1016/S0002-9440(10)63641-3
– volume: 267
  start-page: 10931
  year: 1992
  ident: 10.1016/j.canlet.2009.07.014_bib3
  article-title: Angiogenesis
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)49853-0
– volume: 5
  start-page: 443
  year: 2004
  ident: 10.1016/j.canlet.2009.07.014_bib36
  article-title: Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumourigenesis
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(04)00111-4
– volume: 173
  start-page: 545
  year: 2008
  ident: 10.1016/j.canlet.2009.07.014_bib51
  article-title: Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer’s structures
  publication-title: Am. J. Pathol.
  doi: 10.2353/ajpath.2008.071197
– volume: 6
  start-page: 257
  year: 2006
  ident: 10.1016/j.canlet.2009.07.014_bib7
  article-title: Antiprotease therapy in cancer: hot or not?
  publication-title: Expert Opin. Biol. Ther.
  doi: 10.1517/14712598.6.3.257
– volume: 97
  start-page: 1230
  year: 2006
  ident: 10.1016/j.canlet.2009.07.014_bib18
  article-title: Intracellular proteolytic activity of cathepsin B is associated with capillary-like tube formation by endothelial cells in vitro
  publication-title: J. Cell Biochem.
  doi: 10.1002/jcb.20720
– volume: 29
  start-page: 35
  year: 2008
  ident: 10.1016/j.canlet.2009.07.014_bib48
  article-title: Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgm220
– volume: 83
  start-page: 285
  year: 1995
  ident: 10.1016/j.canlet.2009.07.014_bib15
  article-title: Immunolocalization of cathepsin B in human glioma: implications for tumour invasion and angiogenesis
  publication-title: J. Neurosurg.
  doi: 10.3171/jns.1995.83.2.0285
– volume: 3
  start-page: 721
  year: 2003
  ident: 10.1016/j.canlet.2009.07.014_bib4
  article-title: Targeting HIF-1 for cancer therapy
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1187
– volume: 4
  start-page: 839
  year: 2004
  ident: 10.1016/j.canlet.2009.07.014_bib24
  article-title: Friends or foes – bipolar effects of the tumour stroma in cancer
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1477
– volume: 5
  start-page: 1349
  year: 1998
  ident: 10.1016/j.canlet.2009.07.014_bib28
  article-title: Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review)
  publication-title: Oncol. Rep.
– volume: 2
  start-page: 161
  year: 2002
  ident: 10.1016/j.canlet.2009.07.014_bib30
  article-title: New functions for the matrix metalloproteinases in cancer progression
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc745
– volume: 382
  start-page: 785
  year: 2001
  ident: 10.1016/j.canlet.2009.07.014_bib16
  article-title: Imaging proteolysis by living human glioma cells
  publication-title: Biol. Chem.
  doi: 10.1515/BC.2001.094
– volume: 3
  start-page: 401
  year: 2003
  ident: 10.1016/j.canlet.2009.07.014_bib5
  article-title: Tumourigenesis and the angiogenic switch
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1093
– volume: 26
  start-page: 2069
  year: 2005
  ident: 10.1016/j.canlet.2009.07.014_bib45
  article-title: The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgi183
– volume: 60
  start-page: 6851
  year: 2000
  ident: 10.1016/j.canlet.2009.07.014_bib19
  article-title: Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion
  publication-title: Cancer Rest.
– volume: 26
  start-page: 3357
  year: 2006
  ident: 10.1016/j.canlet.2009.07.014_bib34
  article-title: Cathepsin L affects apoptosis of glioblastoma cells: a potential implication in the design of cancer therapeutics
  publication-title: Anticancer Rest.
– volume: 7
  start-page: 139
  year: 2007
  ident: 10.1016/j.canlet.2009.07.014_bib27
  article-title: The tumour microenvirnment as a target for chemoprevetion
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2067
– volume: 5
  start-page: 559
  year: 1999
  ident: 10.1016/j.canlet.2009.07.014_bib13
  article-title: Cathepsin B immunohistochemical staining in tumour, endothelial cells is a new prognostic factor for survival in patients with brain tumours
  publication-title: Clin. Cancer Rest.
– volume: 3
  start-page: 489
  year: 2003
  ident: 10.1016/j.canlet.2009.07.014_bib10
  article-title: Molecular mechanisms of glioma invasiveness: the role of proteases
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1121
– volume: 19
  start-page: 234
  year: 2005
  ident: 10.1016/j.canlet.2009.07.014_bib31
  article-title: Contribution of host MMP-2 and MMP-9 to promote tumour vascularization and invasion of malignant keratinocytes
  publication-title: FASEB J.
  doi: 10.1096/fj.04-2140fje
– volume: 141
  start-page: 295
  year: 1999
  ident: 10.1016/j.canlet.2009.07.014_bib20
  article-title: Cell–extracellular matrix interaction in glioma invasion
  publication-title: Acta Neurochir. (Wien.)
  doi: 10.1007/s007010050301
– volume: 276
  start-page: 43503
  year: 2001
  ident: 10.1016/j.canlet.2009.07.014_bib49
  article-title: Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M107736200
– volume: 16
  start-page: 430
  year: 2007
  ident: 10.1016/j.canlet.2009.07.014_bib47
  article-title: Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2
  publication-title: Eur. J. Cancer Prev.
  doi: 10.1097/01.cej.0000236259.88146.a4
– volume: 67
  start-page: 305
  year: 2004
  ident: 10.1016/j.canlet.2009.07.014_bib50
  article-title: CXCL12 in malignant glial tumours: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells
  publication-title: J. Neuro-Oncol.
  doi: 10.1023/B:NEON.0000024241.05346.24
– volume: 18
  start-page: 271
  year: 1998
  ident: 10.1016/j.canlet.2009.07.014_bib21
  article-title: Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumours
  publication-title: Invas. Metast.
  doi: 10.1159/000024520
– volume: 439
  start-page: R122
  year: 2000
  ident: 10.1016/j.canlet.2009.07.014_bib12
  article-title: Cathepsin B and its inhibitor stefin A in brain tumours
  publication-title: Pflugers Arch.
  doi: 10.1007/s004240000114
– volume: 313
  start-page: 1192
  year: 2007
  ident: 10.1016/j.canlet.2009.07.014_bib38
  article-title: Glioma-associated endothelial cells show evidence of replicative senescence
  publication-title: Exp. Cell Rest.
  doi: 10.1016/j.yexcr.2006.12.027
– volume: 6
  start-page: 1087
  year: 2006
  ident: 10.1016/j.canlet.2009.07.014_bib2
  article-title: New treatment strategies for malignant gliomas
  publication-title: Expert Rev. Anticancer Ther.
  doi: 10.1586/14737140.6.7.1087
– volume: 281
  start-page: 6020
  year: 2006
  ident: 10.1016/j.canlet.2009.07.014_bib41
  article-title: Cathepsin S controls angiogenesis and tumour growth via matrix-derived angiogenic factors
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M509134200
– volume: 2
  start-page: 737
  year: 2000
  ident: 10.1016/j.canlet.2009.07.014_bib52
  article-title: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogensis
  publication-title: Nat. Cell Biol.
  doi: 10.1038/35036374
– volume: 23
  start-page: 2224
  year: 2004
  ident: 10.1016/j.canlet.2009.07.014_bib39
  article-title: Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1207338
– volume: 208
  start-page: 108
  year: 2006
  ident: 10.1016/j.canlet.2009.07.014_bib53
  article-title: Role of metaloproteinases MMP9 and MT1-MMP in CXCL2-promoted myleoma cell invasion across basement membranes
  publication-title: J. Pathol.
  doi: 10.1002/path.1876
– volume: 145
  start-page: 825
  year: 2003
  ident: 10.1016/j.canlet.2009.07.014_bib11
  article-title: Proteases in brain tumour progression
  publication-title: Acta Neurochir. (Wien.)
  doi: 10.1007/s00701-003-0097-z
– volume: 385
  start-page: 1017
  year: 2004
  ident: 10.1016/j.canlet.2009.07.014_bib29
  article-title: Cysteine cathepsins in human cancer
  publication-title: Biol. Chem.
  doi: 10.1515/BC.2004.132
– volume: 11
  start-page: 1835
  year: 2005
  ident: 10.1016/j.canlet.2009.07.014_bib40
  article-title: Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma
  publication-title: Clin. Cancer Rest.
  doi: 10.1158/1078-0432.CCR-04-1887
– volume: 3/5
  start-page: 362
  year: 2003
  ident: 10.1016/j.canlet.2009.07.014_bib8
  article-title: Tumour-cell invasion and migration: diversity and escape mechanisms
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1075
– volume: 193
  start-page: 367
  year: 2001
  ident: 10.1016/j.canlet.2009.07.014_bib6
  article-title: Endothelial capillaries chemotactically attract tumour cells
  publication-title: J. Pathol.
  doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH810>3.0.CO;2-1
– volume: 23
  start-page: 4681
  year: 2004
  ident: 10.1016/j.canlet.2009.07.014_bib17
  article-title: Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumour cell invasion, tumour growth and angiogenesis
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1207616
– volume: 145
  start-page: 999
  year: 2003
  ident: 10.1016/j.canlet.2009.07.014_bib23
  article-title: Soluble factors involved in glioma invasion
  publication-title: Acta Neurochir. (Wien.)
  doi: 10.1007/s00701-003-0132-0
SSID ssj0005475
Score 2.2466347
Snippet Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to...
Abstract Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 53
SubjectTerms Angiogenesis
Base Sequence
Cancer
Cathepsin B - metabolism
Cathepsins - metabolism
Cell adhesion & migration
Cell culture
Cell Line, Tumor
Cell Proliferation - drug effects
Cells, Cultured
Chemokine CXCL12 - metabolism
Chemokines (CXCL12/SDF-1)
Cysteine cathepsins
Endothelial Cells - cytology
Endothelial Cells - drug effects
Endothelial Cells - pathology
Enzyme-Linked Immunosorbent Assay
Enzymes
Gene expression
Gene Expression Regulation, Enzymologic
Glioblastoma - physiopathology
Glioblastoma invasion
Hematology, Oncology and Palliative Medicine
Humans
Matrix metalloproteases
Matrix Metalloproteinase 9 - metabolism
Molecular Sequence Data
Neoplasm Invasiveness
Paracrine Communication
Protease Inhibitors - pharmacology
Studies
Tumors
Up-Regulation
Title Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0304383509005023
https://www.clinicalkey.es/playcontent/1-s2.0-S0304383509005023
https://dx.doi.org/10.1016/j.canlet.2009.07.014
https://www.ncbi.nlm.nih.gov/pubmed/19700239
https://www.proquest.com/docview/1506050676
https://www.proquest.com/docview/733811545
https://www.proquest.com/docview/745930856
Volume 289
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWqIiEuCMrXQql84LjuJrazXh9LYbuAtkJaKvVm2bEjFrbJimQRXPhL_EVmnKQtKqWIQy6JZ2zZLzMvzsyYkBdCCa8mLmHg6iyTeXzn8oKF4MAbKKGCwnzn-fF4diLfnmanW-Swz4XBsMrO9rc2PVrr7s6om83RerkcLfCnHnxfgcfDIiYcK35KqRDl-z8uhXnIWGwXGzNs3afPxRgvGD3MTle1Uu0nqbzOPV1HP6Mbmt4jdzv-SA_aId4nW6HcIbfn3R_yB-Tn0WpZOaDETXVmqS09DaXHLKsVAI3iNn1NY9cMWPfnIY2ZI8A6qftOF6-mLB2CwEeEQk2bzRl0R5flV4t7ale0rfHEnyK0GEIFyxI5KO4-0PCti7AtaVXQWBx2DQ9q-nJIF8Ooaj5_z_RDcjJ9_eFwxrpDGViecd0waYXTEyV0ruQ45y7lwSueFMIXQeTAXnKuZZHpsVYZT7h1qffOZ14ICwITLx6R7bIqwxNCrQjecu64slLyNIBax70ecxl8OvH5gIh-LUzeVSzHgzNWpg9N-2TaFcTDNLVJlIEVHBB2LrVuK3bc0D7rl9n02ahgPw24lBvk1J_kQt0ZgdqkpuYmMVeAelnyN6z_Q5-7PQ7NRTdYIxIuNR4Qev4YrARiypah2tRGCWBmyJb_0kRmWgABBy2PW4RfTJ9WMQn66X8P_Bm504ZdYPDeLtluvmzCc2BzjduLr-seuXXw5t3s-Bd_HEnn
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLfGkGAXxPcKA3zgWK-J7dT1EQalwDohdZN2s-zYEYEurUiL4MK_xL_Ie06yDY0xxCGXxO_Zsp_f-8V-H4Q8F0p4NXIJA1NnmczjnssLFoIDa6CECgrjnacHw8mRfHecHW-QvS4WBt0qW93f6PSords3g3Y2B8uyHMzwUg_-r8DiYRITLq6R6xK2L5Yx2P1xzs9Dxmy72Jph8y5-Ljp5wfBhetq0lWo3SeVl9uky_Bnt0Pg2udUCSPqiGeMdshGqu-TGtL0iv0d-vpmXCweYeLU4sdRWnobKY5jVHCSN4jl9TWPXDGD35z6NoSMAO6n7TmevxiztA8FHlIWartYn0B0tq68WD9UucFtiyZ8iNEKEDMoKQSgeP9DwrXWxreiioDE77BI-1PRln876kdV0-oHp--Ro_Ppwb8Laqgwsz7heMWmF0yMldK7kMOcu5cErnhTCF0HkAF9yrmWR6aFWGU-4dan3zmdeCAsEIy8ekM1qUYVtQq0I3nLuuLJS8jQAW8e9HnIZfDryeY-Ibi1M3qYsx8oZc9P5pn0yzQpiNU1tEmVgBXuEnVItm5QdV7TPumU2XTgqKFADNuUKOvUnulC3WqA2qam5ScwFST1P-Zuw_0OfO50cmrNuMEkkPGrYI_T0M6gJlClbhcW6NkoANEO4_JcmMtMCEDhwedhI-Nn0aRWjoB_998CfkZuTw-m-2X978P4x2Wp8MNCTb4dsrr6swxOAdiv3NG7dX5xWS3U
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glioblastoma+and+endothelial+cells+cross-talk%2C+mediated+by+SDF-1%2C+enhances+tumour+invasion+and+endothelial+proliferation+by+increasing+expression+of+cathepsins+B%2C+S%2C+and+MMP-9&rft.jtitle=Cancer+letters&rft.au=Kenig%2C+Sasa&rft.au=Alonso%2C+Mar%C3%ADa+Beatriz+Dur%C3%A1n&rft.au=Mueller%2C+Margareta+M&rft.au=Lah%2C+Tamara+T&rft.date=2010-03-01&rft.eissn=1872-7980&rft.volume=289&rft.issue=1&rft.spage=53&rft_id=info:doi/10.1016%2Fj.canlet.2009.07.014&rft_id=info%3Apmid%2F19700239&rft.externalDocID=19700239
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03043835%2FS0304383510X00040%2Fcov150h.gif